Android app on Google Play

JMP Securities Downgrades BioCryst Pharma (BCRX) to Market Perform

November 27, 2012 11:28 AM EST Send to a Friend
Get Alerts BCRX Hot Sheet
Price: $8.65 +1.17%

Rating Summary:
    10 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 22 | Down: 10 | New: 7
Trade BCRX Now!
Join SI Premium – FREE
JMP Securities downgraded BioCryst Pharma (NASDAQ: BCRX) from Market Outperform to Market Perform.

For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.

Shares of BioCryst Pharma closed at $1.48 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

JMP Securities

Add Your Comment